|
|
Did You Have a Alfarol Side Effect? How Effective is Alfarol for You? |
Showing 1-25 of 44 Next Page >
Rash (8443188-8)
on Jun 05, 2012 Male patient from JAPAN , 68 years of age, was treated with Alfarol(View Usage). Patient experienced the following unwanted or unexpected effects: rash (rash Questions). Alfarol dosage: N/A.
Patient was taking other medications:
Liver Disorder, Haemosiderosis, Hepatitis, Fatigue, Periportal Oedema (8406261-6)
Patient was taking Alfarol (View Usage). Patient had the following side effects: liver disorder, haemosiderosis, hepatitis (hepatitis Questions), fatigue, periportal oedema on May 28, 2012 from JAPAN Additional patient health information: Female patient , weighting 79.37 lb, . Alfarol dosage: 0.5 Ug, Unk.
Patient was taking other medications:
Myocardial Ischaemia (8402153-7)
Adverse event was reported on May 18, 2012 by a Female patient taking Alfarol (View Usage) (Dosage: 1 Df, Daily) was diagnosed with
Patient was taking other medications:
Loss Of Consciousness, Road Traffic Accident, Dermatitis (8347374-7)
on May 01, 2012 Male patient from JAPAN , weighting 116.8 lb, was diagnosed with
Patient was taking other medications:
Haemoglobin Decreased, Gastrointestinal Erosion (8338403-5)
on Apr 26, 2012 Male patient from JAPAN , weighting 112.4 lb, was treated with Alfarol(View Usage). Patient had the following side effects: haemoglobin decreased, gastrointestinal erosion. Alfarol dosage: N/A.
Patient was taking other medications:
Macular Oedema (8295906-X)
Patient was taking Alfarol (View Usage). After Alfarol was administered, patient had the following side effects: macular oedema on Apr 02, 2012 from JAPAN Additional patient health information: Female patient , weighting 94.80 lb, was diagnosed with
Patient was taking other medications:
Loss Of Consciousness, Road Traffic Accident, Dermatitis (8282933-1)
Adverse event was reported on Mar 30, 2012 by a Male patient taking Alfarol (View Usage) (Dosage: N/A) was diagnosed with
Patient was taking other medications:
Blood Parathyroid Hormone Increased, Hypocalcaemia, Hyperphosphataemia (8216573-7)
on Mar 07, 2012 Male patient from JAPAN , child 2 years of age, weighting 17.64 lb, was treated with Alfarol (View Usage). Patient had the following side effects: blood parathyroid hormone increased, hypocalcaemia, hyperphosphataemia. Alfarol dosage: 0.5 Mug, Qd.
Patient was taking other medications:
Retinal Haemorrhage (8209552-7)
on Mar 06, 2012 Female patient from JAPAN , 60 years of age, was treated with Alfarol(View Usage). After Alfarol was administered, patient had the following side effects: retinal haemorrhage. Alfarol dosage: N/A.
Patient was taking other medications:
Blood Sodium Increased, Blood Potassium Increased, Blood Creatinine Increased, Blood Urea Increased, Altered State Of Consciousness, Renal Impairment, Urine Output Decreased, Renal Failure Acute, Muscular Weakness (8201533-2)
Patient was taking Alfarol (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium increased, blood potassium increased, blood creatinine increased, blood urea increased, altered state of consciousness, renal impairment, urine output decreased, renal failure acute, muscular weakness on Mar 06, 2012 from JAPAN Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with
Patient was taking other medications:
Feeling Abnormal, Feeling Hot, Flushing, Terminal Dribbling, Pain, Hepatitis, Rash, Dizziness, Insomnia (8199440-7)
Adverse event was reported on Feb 27, 2012 by a Female patient taking Alfarol (View Usage) (Dosage: Unk) . Location: JAPAN , 78 years of age, Patient had the following side effects: feeling abnormal, feeling hot, flushing, terminal dribbling, pain (pain Questions), hepatitis (hepatitis Questions), rash (rash Questions), dizziness (dizziness Questions), insomnia.
Patient was taking other medications:
Hypoaesthesia, Hypocalcaemia, Blood Calcium Decreased, Tetany (8175230-6)
on Feb 16, 2012 Female patient from JAPAN , 38 years of age, was treated with Alfarol (alfacalcidol) (View Usage). After Alfarol was administered, patient had the following side effects: hypoaesthesia, hypocalcaemia, blood calcium decreased, tetany. Alfarol (alfacalcidol) dosage: N/A.
Patient was taking other medications:
Purulent Discharge, Paralysis, Blood Albumin Decreased, No Therapeutic Response, Osteomyelitis, Facial Pain, Inflammation, Exposed Bone In Jaw, Swelling Face (8118759-9)
on Jan 24, 2012 Female patient from JAPAN , 84 years of age, was treated with Alfarol (alfacalcidol)(View Usage). Patient experienced the following unwanted or unexpected effects: purulent discharge, paralysis (paralysis Questions), blood albumin decreased, no therapeutic response, osteomyelitis, facial pain, inflammation, exposed bone in jaw, swelling face. Alfarol (alfacalcidol) dosage: N/A.
Patient was taking other medications:
Liver Disorder (7936706-7)
Patient was taking Alfarol (View Usage). Patient had the following side effects: liver disorder on Nov 11, 2011 from JAPAN Additional patient health information: Female patient , weighting 130.7 lb, . Alfarol dosage: 0.5 Mcg, Qd.
Patient was taking other medications:
Nephrolithiasis, Hydronephrosis (7921348-X)
Adverse event was reported on Nov 08, 2011 by a Male patient taking Alfarol (View Usage) (Dosage: From:peroral Agent, Dosage Is Uncertain) . Location: JAPAN , weighting 103.6 lb, After Alfarol was administered, patient had the following side effects: nephrolithiasis, hydronephrosis.
Patient was taking other medications:
Post Procedural Infection, Cholelithiasis (7919150-8)
on Nov 07, 2011 Female patient from JAPAN , weighting 132.3 lb, was treated with Alfarol (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural infection, cholelithiasis. Alfarol dosage: N/A.
Patient was taking other medications:
Liver Disorder (7913328-5)
on Nov 01, 2011 Female patient from JAPAN , 59 years of age, was treated with Alfarol(View Usage). Patient had the following side effects: liver disorder. Alfarol dosage: Uncertainty.
Patient was taking other medications:
Lymph Node Tuberculosis (7789564-8)
Patient was taking Alfarol (View Usage). After Alfarol was administered, patient had the following side effects: lymph node tuberculosis on Sep 20, 2011 from JAPAN Additional patient health information: Male patient , 31 years of age, weighting 132.3 lb, was diagnosed with
Patient was taking other medications:
Arrhythmia (7759789-6)
Adverse event was reported on Aug 02, 2011 by a Female patient taking Alfarol (View Usage) (Dosage: 0.25 Mug, Qd) was diagnosed with
Patient was taking other medications:
Skin Ulcer, Pneumonia Pneumococcal, Pleurisy, Loss Of Consciousness (7743002-X)
on Sep 01, 2011 Female patient from JAPAN , weighting 114.6 lb, was treated with Alfarol (View Usage). Patient had the following side effects: skin ulcer, pneumonia pneumococcal, pleurisy, loss of consciousness. Alfarol dosage: N/A.
Patient was taking other medications:
Altered State Of Consciousness, Hyponatraemia, Vomiting, Dyskinesia, Headache (7737294-0)
on Aug 30, 2011 Female patient from JAPAN , 68 years of age, weighting 112.4 lb, was diagnosed with
Patient was taking other medications:
Femur Fracture (7734649-5)
Patient was taking Alfarol (View Usage). Patient experienced the following unwanted or unexpected effects: femur fracture on Aug 31, 2011 from JAPAN Additional patient health information: Female patient , 76 years of age, was diagnosed with
Patient was taking other medications:
Cerebral Haemorrhage (7693886-9)
Adverse event was reported on Aug 17, 2011 by a Female patient taking Alfarol (View Usage) (Dosage: 0.25 Mg) . Location: JAPAN , 61 years of age, Patient had the following side effects: cerebral haemorrhage.
Patient was taking other medications:
Aspartate Aminotransferase Increased, Blood Potassium Decreased, Condition Aggravated, Cardiac Failure, Blood Bilirubin Increased, Hepatic Function Abnormal, Blood Sodium Increased, Alanine Aminotransferase Increased (7690306-5)
on Aug 01, 2011 Female patient from JAPAN , 73 years of age, weighting 115.5 lb, was treated with Alfarol (alfacalcidol) (View Usage). After Alfarol was administered, patient had the following side effects: aspartate aminotransferase increased, blood potassium decreased, condition aggravated, cardiac failure, blood bilirubin increased, hepatic function abnormal, blood sodium increased, alanine aminotransferase increased. Alfarol (alfacalcidol) dosage: N/A.
Patient was taking other medications:
Acute Disseminated Encephalomyelitis, Urinary Tract Infection, Lumbar Spinal Stenosis, Disseminated Intravascular Coagulation, Blood Phosphorus Decreased, Platelet Count Decreased, Temperature Intolerance, Blood Potassium Decreased, Tinnitus (7679827-9)
on Aug 03, 2011 Female patient from JAPAN , 70 years of age, weighting 83.78 lb, was treated with Alfarol(View Usage). Patient experienced the following unwanted or unexpected effects: acute disseminated encephalomyelitis, urinary tract infection (urinary tract infection Questions), lumbar spinal stenosis, disseminated intravascular coagulation, blood phosphorus decreased, platelet count decreased, temperature intolerance, blood potassium decreased, tinnitus (tinnitus Questions). Alfarol dosage: Unk.
Patient was taking other medications:
on Jun 05, 2012 Male patient from JAPAN , 68 years of age, was treated with Alfarol(View Usage). Patient experienced the following unwanted or unexpected effects: rash (rash Questions). Alfarol dosage: N/A.
Patient was taking other medications:
- NATEGLINIDE (View Nateglinide Review and Nateglinide Label )
- REBETOL (View Rebetol Review and Rebetol Label )
- PEGINTERFERON ALFA 2B (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label )
- LOCHOLEST (View Locholest Review and Locholest Label )
- TELAVIC (TELAPREVIR) (View Telavic (telaprevir) Review and Telavic (telaprevir) Label )
Liver Disorder, Haemosiderosis, Hepatitis, Fatigue, Periportal Oedema (8406261-6)
Patient was taking Alfarol (View Usage). Patient had the following side effects: liver disorder, haemosiderosis, hepatitis (hepatitis Questions), fatigue, periportal oedema on May 28, 2012 from JAPAN Additional patient health information: Female patient , weighting 79.37 lb, . Alfarol dosage: 0.5 Ug, Unk.
Patient was taking other medications:
- EXJADE (1000 Mg, Daily) (View Exjade Review and Exjade Label )
- FOSAMAX (5 Mg, Unk) (View Fosamax Review and Fosamax Label )
- PRAVASTATIN SODIUM (10 Mg, Unk) (View Pravastatin Sodium Review and Pravastatin Sodium Label )
Myocardial Ischaemia (8402153-7)
Adverse event was reported on May 18, 2012 by a Female patient taking Alfarol (View Usage) (Dosage: 1 Df, Daily) was diagnosed with
- osteoporosis (osteoporosis Questions)
- peripheral circulatory failure
Patient was taking other medications:
- TOCOPHEROL /00110502/ (600 Mg, Daily) (View Tocopherol /00110502/ Review and Tocopherol /00110502/ Label )
- BUPRENORPHINE (View Buprenorphine Review and Buprenorphine Label )
- OLMESARTAN MEDOXOMIL (1 Df, Daily) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label )
Loss Of Consciousness, Road Traffic Accident, Dermatitis (8347374-7)
on May 01, 2012 Male patient from JAPAN , weighting 116.8 lb, was diagnosed with
- renal failure chronic
Patient was taking other medications:
- ARGAMATE (View Argamate Review and Argamate Label )
- MIRCERA (View Mircera Review and Mircera Label )
Haemoglobin Decreased, Gastrointestinal Erosion (8338403-5)
on Apr 26, 2012 Male patient from JAPAN , weighting 112.4 lb, was treated with Alfarol(View Usage). Patient had the following side effects: haemoglobin decreased, gastrointestinal erosion. Alfarol dosage: N/A.
Patient was taking other medications:
- TENORMIN (View Tenormin Review and Tenormin Label )
- OMEPRAZOLE (View Omeprazole Review and Omeprazole Label )
- EPOGIN S (View Epogin S Review and Epogin S Label )
- PLAVIX (View Plavix Review and Plavix Label )
- ATELEC (View Atelec Review and Atelec Label )
- MIRCERA (View Mircera Review and Mircera Label )
Macular Oedema (8295906-X)
Patient was taking Alfarol (View Usage). After Alfarol was administered, patient had the following side effects: macular oedema on Apr 02, 2012 from JAPAN Additional patient health information: Female patient , weighting 94.80 lb, was diagnosed with
- osteoporosis (osteoporosis Questions)
- hypercholesterolaemia
- constipation prophylaxis
- peripheral sensory neuropathy
Patient was taking other medications:
- LIPITOR (View Lipitor Review and Lipitor Label )
- MILMAG (View Milmag Review and Milmag Label )
- LYRICA (View Lyrica Review and Lyrica Label )
Loss Of Consciousness, Road Traffic Accident, Dermatitis (8282933-1)
Adverse event was reported on Mar 30, 2012 by a Male patient taking Alfarol (View Usage) (Dosage: N/A) was diagnosed with
- renal failure chronic
Patient was taking other medications:
- ARGAMATE (View Argamate Review and Argamate Label )
- MIRCERA (View Mircera Review and Mircera Label )
Blood Parathyroid Hormone Increased, Hypocalcaemia, Hyperphosphataemia (8216573-7)
on Mar 07, 2012 Male patient from JAPAN , child 2 years of age, weighting 17.64 lb, was treated with Alfarol (View Usage). Patient had the following side effects: blood parathyroid hormone increased, hypocalcaemia, hyperphosphataemia. Alfarol dosage: 0.5 Mug, Qd.
Patient was taking other medications:
- OXAROL (2.5 Mug, 3 Times/wk -15 Time Execution) (View Oxarol Review and Oxarol Label )
- RENAGEL (250 Mg, Qd) (View Renagel Review and Renagel Label )
Retinal Haemorrhage (8209552-7)
on Mar 06, 2012 Female patient from JAPAN , 60 years of age, was treated with Alfarol(View Usage). After Alfarol was administered, patient had the following side effects: retinal haemorrhage. Alfarol dosage: N/A.
Patient was taking other medications:
- FOLIC ACID (View Folic Acid Review and Folic Acid Label )
- LOXONIN (View Loxonin Review and Loxonin Label )
- PREDNISOLONE (View Prednisolone Review and Prednisolone Label )
- SIMPONI (View Simponi Review and Simponi Label )
- FAMOTIDINE (View Famotidine Review and Famotidine Label )
- RHEUMATREX (View Rheumatrex Review and Rheumatrex Label )
Blood Sodium Increased, Blood Potassium Increased, Blood Creatinine Increased, Blood Urea Increased, Altered State Of Consciousness, Renal Impairment, Urine Output Decreased, Renal Failure Acute, Muscular Weakness (8201533-2)
Patient was taking Alfarol (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium increased, blood potassium increased, blood creatinine increased, blood urea increased, altered state of consciousness, renal impairment, urine output decreased, renal failure acute, muscular weakness on Mar 06, 2012 from JAPAN Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with
- osteoporosis (osteoporosis Questions)
- hypertension
- diabetes mellitus
- constipation (constipation Questions)
Patient was taking other medications:
- MICARDIS (40mg Per Day) (View Micardis Review and Micardis Label )
- METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label )
- ALOSENN (1g Per Day) (View Alosenn Review and Alosenn Label )
- ADONA (AC 17) (90mg Per Day) (View Adona (ac-17) Review and Adona (ac-17) Label )
- GABAPENTIN (400mg Per Day) (View Gabapentin Review and Gabapentin Label )
- CIRCULETIN (75mg Per Day) (View Circuletin Review and Circuletin Label )
- LIVALO (2mg Per Day) (View Livalo Review and Livalo Label )
- VALTREX (3000mg Per Day) (View Valtrex Review and Valtrex Label )
Feeling Abnormal, Feeling Hot, Flushing, Terminal Dribbling, Pain, Hepatitis, Rash, Dizziness, Insomnia (8199440-7)
Adverse event was reported on Feb 27, 2012 by a Female patient taking Alfarol (View Usage) (Dosage: Unk) . Location: JAPAN , 78 years of age, Patient had the following side effects: feeling abnormal, feeling hot, flushing, terminal dribbling, pain (pain Questions), hepatitis (hepatitis Questions), rash (rash Questions), dizziness (dizziness Questions), insomnia.
Patient was taking other medications:
- HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label )
- FORTEO (Unk) (View Forteo Review and Forteo Label )
- PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label )
- DEPAS (Unk) (View Depas Review and Depas Label )
- OLMESARTAN MEDOXOMIL (Unk) (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label )
- CLINORIL (View Clinoril Review and Clinoril Label )
- RABEPRAZOLE SODIUM (Unk) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label )
- LYRICA (Unk) (View Lyrica Review and Lyrica Label )
Hypoaesthesia, Hypocalcaemia, Blood Calcium Decreased, Tetany (8175230-6)
on Feb 16, 2012 Female patient from JAPAN , 38 years of age, was treated with Alfarol (alfacalcidol) (View Usage). After Alfarol was administered, patient had the following side effects: hypoaesthesia, hypocalcaemia, blood calcium decreased, tetany. Alfarol (alfacalcidol) dosage: N/A.
Patient was taking other medications:
- CALCIUIM (CALCIUM) (View Calciuim (calcium) Review and Calciuim (calcium) Label )
- ACTONEL (17.5 Mg Once Daily, Oral) (View Actonel Review and Actonel Label )
Purulent Discharge, Paralysis, Blood Albumin Decreased, No Therapeutic Response, Osteomyelitis, Facial Pain, Inflammation, Exposed Bone In Jaw, Swelling Face (8118759-9)
on Jan 24, 2012 Female patient from JAPAN , 84 years of age, was treated with Alfarol (alfacalcidol)(View Usage). Patient experienced the following unwanted or unexpected effects: purulent discharge, paralysis (paralysis Questions), blood albumin decreased, no therapeutic response, osteomyelitis, facial pain, inflammation, exposed bone in jaw, swelling face. Alfarol (alfacalcidol) dosage: N/A.
Patient was taking other medications:
- RISEDRONATE SODIUM (Oral) (View Risedronate Sodium Review and Risedronate Sodium Label )
- FERROMIA (FERROUS SODIULM CITRATE) (View Ferromia (ferrous Sodiulm Citrate) Review and Ferromia (ferrous Sodiulm Citrate) Label )
- ETODOLAC (View Etodolac Review and Etodolac Label )
- BUFFERIN (View Bufferin Review and Bufferin Label )
- TIZANIN (TIZANIDINE HYDROCHLORIDE) (View Tizanin (tizanidine Hydrochloride) Review and Tizanin (tizanidine Hydrochloride) Label )
- BLOPRESS (CANDESARTAN CILEXETIL) (View Blopress (candesartan Cilexetil) Review and Blopress (candesartan Cilexetil) Label )
- DIART (AZOSEMIDE) (View Diart (azosemide) Review and Diart (azosemide) Label )
- TENORMIN (View Tenormin Review and Tenormin Label )
Liver Disorder (7936706-7)
Patient was taking Alfarol (View Usage). Patient had the following side effects: liver disorder on Nov 11, 2011 from JAPAN Additional patient health information: Female patient , weighting 130.7 lb, . Alfarol dosage: 0.5 Mcg, Qd.
Patient was taking other medications:
- CINACALCET HYDROCHLORIDE (25 Mg, Qd) (View Cinacalcet Hydrochloride Review and Cinacalcet Hydrochloride Label )
- RENAGEL (0.5 G, Tid) (View Renagel Review and Renagel Label )
Nephrolithiasis, Hydronephrosis (7921348-X)
Adverse event was reported on Nov 08, 2011 by a Male patient taking Alfarol (View Usage) (Dosage: From:peroral Agent, Dosage Is Uncertain) . Location: JAPAN , weighting 103.6 lb, After Alfarol was administered, patient had the following side effects: nephrolithiasis, hydronephrosis.
Patient was taking other medications:
- ACTEMRA (View Actemra Review and Actemra Label )
Post Procedural Infection, Cholelithiasis (7919150-8)
on Nov 07, 2011 Female patient from JAPAN , weighting 132.3 lb, was treated with Alfarol (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural infection, cholelithiasis. Alfarol dosage: N/A.
Patient was taking other medications:
- AMLODIPINE (View Amlodipine Review and Amlodipine Label )
- RHYTHMY (Single Use) (View Rhythmy Review and Rhythmy Label )
- DIAZEPAM (Single Use) (View Diazepam Review and Diazepam Label )
- ACTEMRA (View Actemra Review and Actemra Label )
- ZANTAC (View Zantac Review and Zantac Label )
- MORPHINE HCL ELIXIR (View Morphine Hcl Elixir Review and Morphine Hcl Elixir Label )
- MOTILIUM (View Motilium Review and Motilium Label )
- KETOPROFEN (View Ketoprofen Review and Ketoprofen Label )
Liver Disorder (7913328-5)
on Nov 01, 2011 Female patient from JAPAN , 59 years of age, was treated with Alfarol(View Usage). Patient had the following side effects: liver disorder. Alfarol dosage: Uncertainty.
Patient was taking other medications:
- CINACALCET HYDROCHLORIDE (Unk) (View Cinacalcet Hydrochloride Review and Cinacalcet Hydrochloride Label )
- RENAGEL (Uncertainty) (View Renagel Review and Renagel Label )
Lymph Node Tuberculosis (7789564-8)
Patient was taking Alfarol (View Usage). After Alfarol was administered, patient had the following side effects: lymph node tuberculosis on Sep 20, 2011 from JAPAN Additional patient health information: Male patient , 31 years of age, weighting 132.3 lb, was diagnosed with
- prophylaxis
- ankylosing spondylitis (ankylosing spondylitis Questions)
Patient was taking other medications:
- REMICADE (View Remicade Review and Remicade Label )
- ISONIAZID (100df) (View Isoniazid Review and Isoniazid Label )
Arrhythmia (7759789-6)
Adverse event was reported on Aug 02, 2011 by a Female patient taking Alfarol (View Usage) (Dosage: 0.25 Mug, Qd) was diagnosed with
- osteoporosis (osteoporosis Questions)
- gastritis
- iron deficiency anaemia
- cardiac failure
- idiopathic thrombocytopenic purpura
- thrombocytopenia
Patient was taking other medications:
- LANSOPRAZOLE (30 Mg, Prn) (View Lansoprazole Review and Lansoprazole Label )
- FERROUS CITRATE (50 Mg, Qd) (View Ferrous Citrate Review and Ferrous Citrate Label )
- CARVEDILOL (2.5 Mg, Bid) (View Carvedilol Review and Carvedilol Label )
- ROMIPLOSTIM (8 Mug/kg, Qwk) (View Romiplostim Review and Romiplostim Label )
- PREDNISOLONE (5 Mg, Qd) (View Prednisolone Review and Prednisolone Label )
- TAMBOCOR (50 Mg, Bid) (View Tambocor Review and Tambocor Label )
- PIMENOL (50 Mg, Bid) (View Pimenol Review and Pimenol Label )
Skin Ulcer, Pneumonia Pneumococcal, Pleurisy, Loss Of Consciousness (7743002-X)
on Sep 01, 2011 Female patient from JAPAN , weighting 114.6 lb, was treated with Alfarol (View Usage). Patient had the following side effects: skin ulcer, pneumonia pneumococcal, pleurisy, loss of consciousness. Alfarol dosage: N/A.
Patient was taking other medications:
- LOXONIN (View Loxonin Review and Loxonin Label )
- RISEDRONATE SODIUM (View Risedronate Sodium Review and Risedronate Sodium Label )
- AZULFIDINE (View Azulfidine Review and Azulfidine Label )
- PREDNISOLONE (View Prednisolone Review and Prednisolone Label )
- SOLU MEDROL (Start Date And End Date: 29 March 2011) (View Solu-medrol Review and Solu-medrol Label )
- SOLU MEDROL (Start Date And End Date: 31 March 2011) (View Solu-medrol Review and Solu-medrol Label )
- JUVELA (Form: Peroral Agent) (View Juvela Review and Juvela Label )
- SOLU MEDROL (Start Date And End Date: 30 March 2011) (View Solu-medrol Review and Solu-medrol Label )
Altered State Of Consciousness, Hyponatraemia, Vomiting, Dyskinesia, Headache (7737294-0)
on Aug 30, 2011 Female patient from JAPAN , 68 years of age, weighting 112.4 lb, was diagnosed with
- osteoporosis (osteoporosis Questions)
Patient was taking other medications:
- SUCCINYLCHOLINE CHLORIDE INJ (View Succinylcholine Chloride Inj Review and Succinylcholine Chloride Inj Label )
- ATARAX (View Atarax Review and Atarax Label )
- EVISTA (View Evista Review and Evista Label )
- TSUMURA DAIKENTYUTO (View Tsumura Daikentyuto Review and Tsumura Daikentyuto Label )
- DIPRIVAN (View Diprivan Review and Diprivan Label )
- POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label )
- PANTOSIN (View Pantosin Review and Pantosin Label )
- SOFT SANTEAR (View Soft Santear Review and Soft Santear Label )
Femur Fracture (7734649-5)
Patient was taking Alfarol (View Usage). Patient experienced the following unwanted or unexpected effects: femur fracture on Aug 31, 2011 from JAPAN Additional patient health information: Female patient , 76 years of age, was diagnosed with
- osteoporosis (osteoporosis Questions)
Patient was taking other medications:
- PYRIDOXAL PHOSPHATE (View Pyridoxal Phosphate Review and Pyridoxal Phosphate Label )
- KENTON (VITAMIN E NICOTINATE) (View Kenton (vitamin E Nicotinate) Review and Kenton (vitamin E Nicotinate) Label )
- PREDNISOLONE (View Prednisolone Review and Prednisolone Label )
- MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label )
- FOSAMAX (View Fosamax Review and Fosamax Label )
- METALCAPTASE (View Metalcaptase Review and Metalcaptase Label )
- DORNER (View Dorner Review and Dorner Label )
- LIPITOR (View Lipitor Review and Lipitor Label )
Cerebral Haemorrhage (7693886-9)
Adverse event was reported on Aug 17, 2011 by a Female patient taking Alfarol (View Usage) (Dosage: 0.25 Mg) . Location: JAPAN , 61 years of age, Patient had the following side effects: cerebral haemorrhage.
Patient was taking other medications:
- RABEPRAZOLE SODIUM (10 Mg) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label )
- EXFORGE (View Exforge Review and Exforge Label )
- LASIX (40 Mg) (View Lasix Review and Lasix Label )
- FOSRENOL (1500 Mg) (View Fosrenol Review and Fosrenol Label )
- CALCIUM COMPOUNDS AND PREPARATIONS (2000 Mg) (View Calcium Compounds And Preparations Review and Calcium Compounds And Preparations Label )
- TRANEXAMIC ACID (2250 Mg) (View Tranexamic Acid Review and Tranexamic Acid Label )
- PRADAXA (220 Mg) (View Pradaxa Review and Pradaxa Label )
- DOXAZOSIN MESYLATE (2 Mg) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label )
Aspartate Aminotransferase Increased, Blood Potassium Decreased, Condition Aggravated, Cardiac Failure, Blood Bilirubin Increased, Hepatic Function Abnormal, Blood Sodium Increased, Alanine Aminotransferase Increased (7690306-5)
on Aug 01, 2011 Female patient from JAPAN , 73 years of age, weighting 115.5 lb, was treated with Alfarol (alfacalcidol) (View Usage). After Alfarol was administered, patient had the following side effects: aspartate aminotransferase increased, blood potassium decreased, condition aggravated, cardiac failure, blood bilirubin increased, hepatic function abnormal, blood sodium increased, alanine aminotransferase increased. Alfarol (alfacalcidol) dosage: N/A.
Patient was taking other medications:
- CETAPRIL (ALACEPRIL) (View Cetapril (alacepril) Review and Cetapril (alacepril) Label )
- ALLOPURINOL (View Allopurinol Review and Allopurinol Label )
- ACARDI (PIMOBENDAN) (View Acardi (pimobendan) Review and Acardi (pimobendan) Label )
- MEXITIL (View Mexitil Review and Mexitil Label )
- ALDACTONE (View Aldactone Review and Aldactone Label )
- AMARYL (View Amaryl Review and Amaryl Label )
- ZANTAC (View Zantac Review and Zantac Label )
- PREDNISOLONE (PREDNISOLONE SODIUM PHOSPHATE) (View Prednisolone (prednisolone Sodium Phosphate) Review and Prednisolone (prednisolone Sodium Phosphate) Label )
Acute Disseminated Encephalomyelitis, Urinary Tract Infection, Lumbar Spinal Stenosis, Disseminated Intravascular Coagulation, Blood Phosphorus Decreased, Platelet Count Decreased, Temperature Intolerance, Blood Potassium Decreased, Tinnitus (7679827-9)
on Aug 03, 2011 Female patient from JAPAN , 70 years of age, weighting 83.78 lb, was treated with Alfarol(View Usage). Patient experienced the following unwanted or unexpected effects: acute disseminated encephalomyelitis, urinary tract infection (urinary tract infection Questions), lumbar spinal stenosis, disseminated intravascular coagulation, blood phosphorus decreased, platelet count decreased, temperature intolerance, blood potassium decreased, tinnitus (tinnitus Questions). Alfarol dosage: Unk.
Patient was taking other medications:
- FOSAMAX (Unk) (View Fosamax Review and Fosamax Label )
- ASPARA CA (Unk) (View Aspara-ca Review and Aspara-ca Label )
- PRELONE (Unk) (View Prelone Review and Prelone Label )
- PROGRAF (Unk) (View Prograf Review and Prograf Label )
Showing 1-25 of 44 Next Page >
Alfarol Forum
Alfarol Adverse Effect Reports (FDA)
Alfarol InformationSide Effects reported to FDA: 44. View FDA Adverse Reports Alfarol safety alerts: No Reported deaths: 5 Reported hospitalizations: 25 |
Alfarol Side Effects